A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression

Title
A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression
Authors
Keywords
Entinostat, Lapatinib, HER2-overexpressing breast cancer, FOXO3, Bim1
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 146, Issue 2, Pages 259-272
Publisher
Springer Nature
Online
2014-06-11
DOI
10.1007/s10549-014-3014-7

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started